More OncoSil Medical Ltd news
OncoSil Medical LtdASX: OSL

Further commercial milestones achieved in Spain

Apr 23, 2023 at 11:36 PM EDT · Issued by OncoSil Medical Ltd

Filed with ASX · Apr 23, 2023 at 11:36 PM EDT

On 6ix: 6ix.com/news/further-commercial-milestones-achieved-in-spain

Oncosil Medical Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

OncoSil Medical Ltd on 6ix

Story so far

  • OncoSil achieves milestone of 10 patients treated in SpainDec 15, 2022
  • Patient treated in Spain proceeds to successful resectionJul 19, 2022
  • OncoSil Signs Commercial Agreement With Hospital In SpainApr 29, 2022

Earlier from OncoSil Medical

  • Additional Binding Commitment Received for Entitlement OfferApr 21, 2023
  • Non-renounceable Rights Issue Offer ProspectusMar 19, 2023
  • Commitment received for Offer and updated TimetableMar 17, 2023
  • Entitlement Offer PresentationMar 16, 2023
  • Entitlement Offer to raise up to $9.9 millionMar 16, 2023

Later from OncoSil Medical

  • Oral presentation at The Mayo Clinic IMPACT CourseApr 23, 2023
  • First year anniversary of the OSPREY post-marketing registryApr 30, 2023
  • OncoSil to streamline operating structureMay 1, 2023
  • First patient enrolled in the TRIPP-FFX Clinical StudyMay 2, 2023
  • First patient treatment in ItalyMay 21, 2023
All OncoSil Medical news releases↗

Follow OncoSil Medical into a list and get an email when it puts out news.

Follow OncoSil Medical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer